Filing Details
- Accession Number:
- 0001209191-22-024534
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-15 18:24:23
- Reporting Period:
- 2022-04-13
- Accepted Time:
- 2022-04-15 18:24:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1527753 | Personalis Inc. | PSNL | Services-Medical Laboratories (8071) | 275411038 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1779811 | Stephen John West | C/O Personalis, Inc. 1330 O'Brien Drive Menlo Park CA 94025 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-04-13 | 64,430 | $1.84 | 404,221 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-04-13 | 64,430 | $0.00 | 339,791 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2022-04-13 | 64,430 | $0.00 | 64,430 | $1.84 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2023-12-11 | No | 4 | D | Direct |
Footnotes
- The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- This reflects a reduction of 13 shares due to a scrivener's error on the reporting person's prior filings and does not indicate a purchase and/or sale of such shares.
- The weighted average sale price for the transaction reported was $7.40, and the range of prices were between $7.31 and $7.57. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- The shares subject to the option are fully vested and exercisable.